Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
6.20
-0.09 (-1.43%)
At close: Apr 28, 2026, 4:00 PM EDT
6.16
-0.04 (-0.65%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $454.13 million as of April 29, 2026. Its market cap has increased by 93.44% in one year.
Market Cap
454.13M
Enterprise Value
383.43M
1-Year Change
93.44%
Ranking
Category
Stock Price
$6.20
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $454.13M, an increase of 104.21%. That is a compound annual growth rate of 16.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 454.13M | 46.41% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADC Therapeutics | 501.13M |
| 4D Molecular Therapeutics | 479.88M |
| Armata Pharmaceuticals | 473.30M |
| Prelude Therapeutics | 472.60M |
| Larimar Therapeutics | 471.63M |
| Valneva SE | 470.89M |
| Aura Biosciences | 466.73M |
| Contineum Therapeutics | 463.34M |